Latest Articles
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study - Cureus
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study Cureus
Published: May 24, 2025, 12:37 a.m.
Association Between Dietary Selenium Intake and Endometriosis Risk: A Cross-Sectional Analysis - Frontiers
Association Between Dietary Selenium Intake and Endometriosis Risk: A Cross-Sectional Analysis Frontiers
Published: May 23, 2025, 9:11 p.m.
Dr Lantsman on Future Directions for Evaluating Dostarlimab/Chemo in Endometrial Cancer - OncLive
Dr Lantsman on Future Directions for Evaluating Dostarlimab/Chemo in Endometrial Cancer OncLive
Published: May 23, 2025, 7:05 p.m.
Endometriosis linked with increased risk of autoimmune disease - Yahoo Finance
Endometriosis linked with increased risk of autoimmune disease Yahoo Finance
Published: May 23, 2025, 4:21 p.m.
Endometriosis linked with increased risk of autoimmune disease - Clinical Trials Arena
Endometriosis linked with increased risk of autoimmune disease Clinical Trials Arena
Published: May 23, 2025, 3:24 p.m.
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3 - Fierce Biotech
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3 Fierce Biotech
Published: May 23, 2025, 1:22 p.m.
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 - Fierce Biotech
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 Fierce Biotech
Published: May 23, 2025, 1:22 p.m.
Endometrial Ablation Market projected to reach USD 2,052.22 Million by 2034, growing at a CAGR of 5.1% - openPR.com
Endometrial Ablation Market projected to reach USD 2,052.22 Million by 2034, growing at a CAGR of 5.1% openPR.com
Published: May 23, 2025, 12:38 p.m.
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment - TipRanks
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment TipRanks
Published: May 23, 2025, 10:59 a.m.
Living with endometriosis: Fermanagh woman shares her courageous story - The Impartial Reporter
Living with endometriosis: Fermanagh woman shares her courageous story The Impartial Reporter
Published: May 23, 2025, 9:27 a.m.
Link copied to clipboard!